Fusion proteins
Maximize your fusion protein production with our state-of-the-art development and manufacturing methods.
Why develop fusion proteins?
Created by combining two or more proteins, fusion proteins have the potential to revolutionize the treatment of a wide range of diseases, improving the lives of large patient populations.
Some of the key advantages of using fusion proteins as therapeutics include:
- Target specificity: Designed to target specific cells or tissues, the use of fusion proteins can reduce the risk of side effects
- Enhanced potency: The combination of the functions of two or more proteins can result in enhanced potency
- Improved stability and solubility: The engineering of fusions can enhance protein stability and solubility, which can improve therapeutic potential
Understanding our fusion protein production
With our team of expert and experienced scientists and state-of-the-art facilities for the expression, purification, and formulation of fusion proteins, we can expedite your development and manufacturing to reach the market at speed.
Why partner with Enzene for fusion proteins?
We are a global CDMO and biosimilar developer dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
We understand that each modality has unique requirements, and we are committed to providing you with the highest quality products and services. Our flexible development and manufacturing platforms allow us to quickly and efficiently produce modalities, regardless of their complexity or scale.
Our proprietary continuous bioprocess manufacturing platform, EnzeneX™ further enhances production, with accelerated rates and a significant reduction in the cost of producing complex modalities — from mAbs to complex proteins.
Related case studies
Latest resources
A modality for every need
Fueled by our continuous innovation and armed with our wide variety of modalities, we are dedicated to bringing your biologics innovations to life.